|
|||||
|
|
Harnessing mutual exclusivity between TP53 and ARID1 A mutations |
|
| Authors: | Shuai Wu Nail Fatkhutdinov |
| Affiliation: | 1. Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, USA;2. Kazan Federal University, Kazan, Russia |
| Abstract: | |
| Keywords: | SWI/SNF ARID1 A Epithelial ovarian cancer HDAC6 inhibitor immunotherapy HDAC6 TP53 |